An estimated 50 million people worldwide have dementia, with Alzheimer’s disease—accounting for more than 70%—being the representative neurodegenerative brain disorder. A Korean research team has, for the first time, identified at the molecular level that tau and amyloid-β, the two key pathological proteins of Alzheimer’s disease, directly communicate to regulate toxicity.
This article was originally published on MedicalXpress.com